@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-WVZ61GT7-0
  skos:prefLabel "tendances (Qualificatif)"@fr, "trends (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-DQZXN6GJ-K
  skos:prefLabel "Drug Compounding"@en, "Préparation de médicament"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-D691XVQB-H .

jvr:-B5N6FDJK-9
  skos:prefLabel "Formes posologiques"@fr, "Dosage Forms"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-D691XVQB-H .

jvr:-KFM33PF8-L
  skos:prefLabel "médecine vétérinaire (Qualificatif)"@fr, "veterinary (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-GX844VQL-G
  skos:prefLabel "instrumentation (Qualifier)"@en, "instrumentation (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PPKJKFKK-V
  skos:prefLabel "ethics (Qualifier)"@en, "éthique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BL18XJBS-9
  skos:prefLabel "Agents aversifs"@fr, "Aversive Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-D691XVQB-H .

jvr:-SDPG013V-D
  skos:prefLabel "psychology (Qualifier)"@en, "psychologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VZXKBM75-9
  skos:prefLabel "Central Nervous System Agents"@en, "Agents du système nerveux central"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-D691XVQB-H .

jvr:-WJSMRGQV-L
  skos:prefLabel "statistiques et données numériques (Qualificatif)"@fr, "statistics & numerical data (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SDXQ5280-F
  skos:prefLabel "mortality (Qualifier)"@en, "mortalité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X54P965S-Q
  skos:prefLabel "Agents du système nerveux sensoriel"@fr, "Sensory System Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-D691XVQB-H .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZS2PPRXB-V
  skos:prefLabel "Systèmes de délivrance de médicaments"@fr, "Drug Delivery Systems"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-D691XVQB-H .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D691XVQB-H
  skos:related jvr:-DQZXN6GJ-K ;
  skos:prefLabel "Abuse-Deterrent Formulations"@en, "Formulations dissuadant les abus"@fr ;
  skos:altLabel "Formulations de dissuasion des abus"@fr, "Abuse-Deterrent Formulation"@en, "Formulations dissuasives des abus"@fr ;
  dc:modified "2020-05-27"^^xsd:date ;
  skos:broader jvr:-ZS2PPRXB-V, jvr:-B5N6FDJK-9, jvr:-X54P965S-Q, jvr:-VZXKBM75-9 ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000075162> ;
  mesh:allowableQualifier jvr:-SDPG013V-D, jvr:-R3QWLHRG-V, jvr:-GX844VQL-G, jvr:-K3JH4VF9-N, jvr:-KFM33PF8-L, jvr:-NB0XHT3S-N, jvr:-WVZ61GT7-0, jvr:-JVKFK2NX-2, jvr:-SBNWSM1T-R, jvr:-WJSMRGQV-L, jvr:-CB30NGKB-3, jvr:-SDXQ5280-F, jvr:-PPKJKFKK-V, jvr:-W6SQV79N-S ;
  dc:established "2018-01-01"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  skos:narrower jvr:-BL18XJBS-9 ;
  skos:inScheme jvr: ;
  dc:created "2017-07-11"^^xsd:date ;
  skos:definition "Drug formulations or delivery systems intended to discourage the abuse of CONTROLLED SUBSTANCES. These may include physical barriers to prevent chewing or crushing the drug; chemical barriers that prevent extraction of psychoactive ingredients; agonist-antagonist combinations to reduce euphoria associated with abuse; aversion, where controlled substances are combined with others that will produce an unpleasant effect if the patient manipulates the dosage form or exceeds the recommended dose; delivery systems that are resistant to abuse such as implants; or combinations of these methods."@en .

jvr:-JVKFK2NX-2
  skos:prefLabel "nursing (Qualifier)"@en, "soins infirmiers (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K3JH4VF9-N
  skos:prefLabel "methods (Qualifier)"@en, "méthodes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .